Home
About
Overview
Sharing Data
ORCID
Help
History (21)
Precision diabetes: Lessons learned from maturity-onset diabetes of the young (MODY).
Monogenic Diabetes: Next Generation Diagnosis, Treatment and Complications
Another battle won in the phage-host arms race: Pseudomonas phage blocks quorum sensing regulator LasR.
Iatrogenic Hyperinsulinemia, Not Hyperglycemia, Drives Insulin Resistance in Type 1 Diabetes as Revealed by Comparison With GCK-MODY (MODY2).
EGFR pharmacogenomics: the story continues to mutate and evolve.
See All 21 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
EGFR pharmacogenomics: the story continues to mutate and evolve.
EGFR pharmacogenomics: the story continues to mutate and evolve. Am J Pharmacogenomics. 2005; 5(2):137-9.
View in:
PubMed
subject areas
Carcinoma, Non-Small-Cell Lung
Clinical Trials, Phase III as Topic
ErbB Receptors
Humans
Lung Neoplasms
Mutation
Pharmacogenetics
Protein-Tyrosine Kinases
Quinazolines
Randomized Controlled Trials as Topic
authors with profiles
Mark Ratain